Question 1

How many shares of CRNX does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q1, BlackRock, Inc. holds 8.5M shares of CRNX (CRINETICS PHARMACEUTICALS IN).

Question 2

What is BlackRock, Inc.'s CRNX position worth?

Accepted Answer

As of 2026-Q1, BlackRock, Inc.'s CRNX position is worth $308M.

Question 3

Is BlackRock, Inc. buying or selling CRNX?

Accepted Answer

In 2026-Q1, BlackRock, Inc. increased their CRNX position (+6.1% change in shares).

Question 4

When did BlackRock, Inc. first buy CRNX?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in CRNX in 2024-Q4. They have held the position across 6 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Increased	8.5M	+6.1%	$308M	0.0%	$40.12	33
2025-Q4	Increased	8M	+5.3%	$371.9M	0.0%	$47.39	33
2025-Q3	Increased	7.6M	+2.3%	$316M	0.0%	$43.51	32
2025-Q2	Decreased	7.4M	-3.1%	$213.4M	0.0%	$29.96	0
2025-Q1	Increased	7.7M	+1.9%	$256.8M	0.0%	$34.73	31
2024-Q4	New	7.5M	-	$384.3M	0.0%	$50.67	43

CRNX6 quarters

CRNX
6 quarters